Activatory properties of lysophosphatidic acid on human THP-1 cells

Inflammation

Volumn 30, Issue 5, 2007, Pages 167-177

  D'Aquilio, F ^a   Procaccini, M ^a   Izzi, V ^a   Chiurchiu', V ^a   Giambra, V ^a   Carotenuto, F ^a   Di Nardo, P ^a   Baldini, P M ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Arachidonic acid metabolites; LPA receptors; Lysophosphatidic acid; Proliferation; Reactive oxygen intermediates

Indexed keywords

ARACHIDONIC ACID; LEUKOTRIENE B4; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CELL ACTIVATION; CELL GROWTH; CELL PROLIFERATION; DNA SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE; MEDIATOR RELEASE; MONOCYTE; PLEIOTROPY; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION;

ARACHIDONIC ACID; CELL LINE; CELL PROLIFERATION; DINOPROSTONE; DNA REPLICATION; ENZYME ACTIVATION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; ISOXAZOLES; LEUKOTRIENE B4; LYSOPHOSPHOLIPIDS; MONOCYTES; NADPH OXIDASE; PROPIONIC ACIDS; REACTIVE OXYGEN SPECIES; RECEPTORS, LYSOPHOSPHATIDIC ACID; RNA, MESSENGER; TIME FACTORS; UP-REGULATION;

EID: 35348924191     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10753-007-9034-2     Document Type: Article

References (29)

1. Moolenaar, W. H. 2000. Development of our current understanding of bioactive lysophospholipids. Ann. NY Acad. Sci. 905:1-10.
2. Fukushima, N., and J. Chun. 2001. The LPA receptors. Prostaglandins. 64:21-32.
3. Goetzl, E. J., W. Wang, G. McGiffert, M. G. Huang, and M. H. Graler. 2004. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J. Cell. Biochem. 92(6):1104-1114.
4. Graler, M. H., and E. J. Goetzl. 2002. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta. 1582(1-3):168-174.
5. Siess, W., K. J. Zangle, M. Essler, M. Bauer, R. Brandl, C. Corrinth, R. Bittman, G. Tigyi, and M. Aepfelbacher. 1999. Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl. Acad. Sci. U S A. 96(12):6931-6936.
6. Panther, E., M. Idzko, S. Corinti, D. Ferrari, Y. Herouy, M. Mockenhaupt, S. Dichmann, P. Gebicke-Haerter, F. Di Virgilio, G. Girolomoni, and J. Norgauer. 2002. The influence of lysophosphatidic acid on the functions of human dendritic cells. J. Immunol. 169(8):4129-4135.
7. Andres, V., and C. Castro. 2003. Antiproliferative strategies for the treatment of vascular proliferative disease. Curr. Vasc. Pharmacol. 1:85-98.
8. Ross, R. 1999. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340(2):115-126.
9. Osterud, B., and E. Bjorklid. 2003. Role of monocytes in atherogenesis. Physiol. Rev. 83(4):1069-1112.
10. Melo, R. C. N., D. L. Fabrino, H. D'Ávila, H. C. Teixeira, and A. P. Ferreira. 2003. Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo. Cell. Biol. Int. 27(10):853-861.
11. Babior, B. M. 1999. NADPH oxidase: an update. Blood. 93:1464-1476.
12. Hadjigogos, K. 2003. The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med. 45(1):7-13.
13. Lu, Y., and L. M. Wahl. 2005. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J. Immunol. 175(8):5423-5429.
14. Vila, L. 2004. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med. Res. Rev. 24(4):399-424.
15. Shen, H. M., C. Y. Shi, Y. Shen, and C. N. Ong. 1996. Detection of elevated reactive oxygen species level in cultured rat hepatocytes treated with aflatoxin B1. Free Radic. Biol. Med. 21:139-146.
16. Donchenko, V., A. Zannetti, and P. M. Baldini. 1994. Insulin-stimulated hydrolysis of phosphatidylcholine by phospholipase C and phospholipase D in cultured rat hepatocytes. Biochim. Biophys. Acta. 1222(3):492-500.
17. Johann, A. M., A. von Knethen, D. Lindemann, and B. Brüne. 2006. Recognition of apoptotic cells by macrophages activates the peroxisome proliferator-activated receptor-gamma and attenuates the oxidative burst. Cell Death Differ. 13(9):1533-1540.
18. 2+ and contractility in cultured rat mesangial cells. Circ. Res. 77(5):888-896.
19. Pebay, A., Y. Torrens, M. Toutant, J. Cordier, J. Glowinski, and M. Tence. 1999. Pleiotropic effects of lysophosphatidic acid on striatal astrocytes. Glia. 28(1):25-33.
20. Fueller, M., D. A. Wang, G. Tigyi, and W. Siess. 2003. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate. Cell. Signal. 15(4):367-375.
21. Nakamoto, T., K. Yasuda, M. Yasuhara, T. Yoshimura, T. Kinoshita, T. Nakajima, H. Okada, A. Ikuta, and H. Kanzaki. 2005. Expression of the endothelial cell differentiation gene 7 (EDG-7), a lysophosphatidic acid receptor, in ovarian tumor. J. Obstet. Gynaecol. Res. 31(4):344-351.
22. Ohta, H., K. Sato, N. Murata, A. Damirin, E. Malchinkhuu, J. Kon, T. Kimura, M. Tobo, Y. Yamazaki, T. Watanabe, M. Yagi, M. Sato, R. Suzuki, H. Murooka, T. Sakai, T. Nishitoba, D. S. Im, H. Nochi, K. Tamoto, H. Tomura, and F. Okajima. 2003. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 64(4):994-1005.
23. Baldini, P. M., P. De Vito, F. D'Aquilio, D. Vismara, F. Zalfa, C. Bagni, R. Fiaccavento, and P. Di Nardo. 2005. Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth. Mol. Cell. Biochem. 272(1-2):19-28.
24. Wang, L., E. Knudsen, Y. Jin, S. Gessani, and A. A. Maghazachi. 2004. Lysophospholipids and chemokines activate distinct signal transduction pathways in T helper 1 and T helper 2 cells. Cell. Signal. 16(9):991-1000.
25. Rosskopf, D., W. Daelman, S. Busch, M. Schürks, K. Hartung, A. Kribben, M. C. Michel, and W. Siffert. 1998. Growth factor-like action of lysophosphatidic acid on human B lymphoblasts. Am. J. Physiol. 274(6):C1573-C1582.
26. Martindale, J. L., and N. J. Holbrook. 2002. Cellular response to oxidative stress: signalling for suicide and survival. J. Cell. Physiol. 192(1):1-15.
27. Cathcart, M. K. 2004. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24(1):23-28.
28. Anliker, B., and J. Chun. 2004. Cell surface in lysophospholipid signalling. Semin. Cell Dev. Biol. 15(5):457-465.
29. Siess, W. 2002. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim. Biophys. Acta. 1582:204-215.